Multiple myeloma is often not recognized by primary physicians, leading to challenges in symptom identification and access to tests.

Patients face difficulties reaching haematologists, especially in countries with specialist shortages.

High medication costs and treatment side effects complicate care, particularly for older patients.

Despite these issues, improving patient outreach and connections to the right physicians can enhance health outcomes and quality of life.